Roivant Sciences (ROIV) Assets (2021 - 2026)

Roivant Sciences has reported Assets for 6 years, with the latest figure at $5.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 5.0% year-over-year to $5.7 billion; the trailing twelve-month figure through Mar 2026 stood at $5.7 billion (up 5.0% YoY), and the FY2026 full-year result was $5.7 billion, up 5.0% from the prior year.
• Assets for Q1 2026 stood at $5.7 billion, up from $5.2 billion in the prior quarter.
• The five-year high for Assets was $7.3 billion in Q4 2023, with the low at $2.1 billion in Q3 2023.
• Historically, Assets has averaged $4.5 billion across 5 years, with a median of $5.1 billion in 2025.
• Annual changes were most pronounced in 2022 — Assets slipped 28.6% — and 2023, when it soared 231.95%.
• Roivant Sciences' Assets stood at $2.2 billion in 2022, then soared by 231.95% to $7.3 billion in 2023, then fell by 20.79% to $5.8 billion in 2024, then fell by 9.79% to $5.2 billion in 2025, then rose by 9.25% to $5.7 billion in 2026.
• The last three Assets figures came in at $5.7 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.1 billion (Q3 2025), per Business Quant data.